Folliman
Established Member
- Reaction score
- 204
It's recruiting participants already! :O
https://clinicaltrials.gov/ct2/show/NCT02563067?term=QAW039&rank=1
https://clinicaltrials.gov/ct2/show/NCT02563067?term=QAW039&rank=1
Crth2 Antagonist Aims To Finalize Phase 3 Trials In 2018
- Thread starter Folliman
- Start date
may be they report it as a side effect if significant regrowth occur.
while speaking of CRTH2 antagonist i found this.
http://www.sciencedirect.com/science/article/pii/S0165247806001234
i dont know whether you guys have already discussed it or not but it seems like this component blocks COX2 which leads to PGD2 synthesis and crth2 immune response as well.
this is a product for Androgenetic Alopecia by a company FAGRON which is using same component.
https://gr.fagron.com/en-gr/product-innovations/prostaquinonr
http://www.sciencedirect.com/science/article/pii/S0165247806001234
i dont know whether you guys have already discussed it or not but it seems like this component blocks COX2 which leads to PGD2 synthesis and crth2 immune response as well.
this is a product for Androgenetic Alopecia by a company FAGRON which is using same component.
https://gr.fagron.com/en-gr/product-innovations/prostaquinonr
